Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Bueser, T.

  • Google
  • 1
  • 12
  • 0

King's College London

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2023QGenome: a smart app-based clinical decision aid for inherited cardiac conditionscitations

Places of action

Chart of shared publication
Kulkarni, A.
1 / 9 shared
Wafik, M.
1 / 1 shared
Carley, H.
1 / 1 shared
Bastiaenen, R.
1 / 1 shared
Wierzbicki, T.
1 / 1 shared
Cross, S.
1 / 1 shared
Kenney, A.
1 / 1 shared
Bustillo, B.
1 / 1 shared
Tripathi, V.
1 / 1 shared
Tomlinson, C.
1 / 1 shared
Frampton, K.
1 / 2 shared
Robert, L.
1 / 1 shared
Chart of publication period
2023

Co-Authors (by relevance)

  • Kulkarni, A.
  • Wafik, M.
  • Carley, H.
  • Bastiaenen, R.
  • Wierzbicki, T.
  • Cross, S.
  • Kenney, A.
  • Bustillo, B.
  • Tripathi, V.
  • Tomlinson, C.
  • Frampton, K.
  • Robert, L.
OrganizationsLocationPeople

article

QGenome: a smart app-based clinical decision aid for inherited cardiac conditions

  • Kulkarni, A.
  • Wafik, M.
  • Carley, H.
  • Bastiaenen, R.
  • Wierzbicki, T.
  • Cross, S.
  • Kenney, A.
  • Bustillo, B.
  • Tripathi, V.
  • Tomlinson, C.
  • Frampton, K.
  • Robert, L.
  • Bueser, T.
Abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Funding Acknowledgements</jats:title><jats:p>Type of funding sources: Public Institution(s). Main funding source(s): Guy’s and St Thomas’ Charity</jats:p><jats:p>South East Genomic Medicine Service Alliance</jats:p></jats:sec><jats:sec><jats:title>Background</jats:title><jats:p>QGenome is a smart application designed by a Regional Genetics service, in partnership with a Genomic Medicine Service Alliance (GMSA) and a technology company. The aims were to facilitate streamlined genomic testing, risk assessment, and referral guidance to relevant healthcare professionals in primary, secondary, and tertiary care settings; and to provide equity of "Genomics care" for patients across the UK, through standardized genomic testing and referral pathways.</jats:p><jats:p>Due to high clinical demand, and following a design workshop with stakeholders, the initial version of QGenome was implemented for Cancer Genomics pathways. The scope has been extended to include workflows for Cardiology and Renal Genomics. The current Inherited Cardiac Conditions (ICC) workflow includes initial genomic testing/risk assessment pathways developed for familial hypercholesterolaemia, long QT syndrome, and vascular Ehlers Danlos Syndrome (vEDS).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>For each clinical indication/condition, QGenome provides workflow assessments to determine eligibility for genomic testing and/or specialist tertiary referral. The workflow takes the user through a series of questions about their patient’s personal, past medical, and family history in a user-friendly format, to assess inherited susceptibility to disease.</jats:p><jats:p>Eligibility criteria are derived from the UK National Genomic Test Directory, published literature and guidance from relevant advisory board working groups.</jats:p><jats:p>The app can be used to find relevant forms, save reports, and activate referrals to specialist services or genetics clinics. QGenome is freely available on iOS, android and web-based platforms.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The ICC workflows are demonstrated through the vEDS case studies (Figure).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>QGenome offers a quick, efficient clinical decision tool for healthcare professionals, including cardiovascular nurses and allied professionals, in busy clinical settings, to differentiate between patients with likely sporadic cardiac disease and those with probable genetic/hereditary susceptibility for ICC.</jats:p></jats:sec>

Topics
  • impedance spectroscopy
  • size-exclusion chromatography
  • susceptibility